LeadingBiotech’s Boston CEO&BD Conference Joins BioPharm America™ for a Must-Attend September Event

Share Article

Stay at the forefront of biotech innovation by tapping into the richest pool of finance, experience and talent.

Boston CEO&BD
“Although we are unable to convene in person this year, we are thrilled to be welcoming all of our fantastic speakers digitally and to be offering our attendees an expanded reach across all of BioPharm America,” Wendy Nelson, CEO, LeadingBiotech.

LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston CEO and Boston BD conferences are now one live virtual event to be held on September 22. Boston CEO&BD has joined with BioPharm America™ to offer the full content and partnering of the combined digitally-offered events to its attendees September 21–24.

Stay at the forefront of biotech innovation by tapping into the richest pool of finance, experience and talent. Boston CEO&BD provides an opportunity for attendees to leverage insight from real-life business development experiences, network with biopharma executives and share insights on the business challenges and opportunities impacting the industry.

Key topics at this year’s conference include the Role of Patient Advocacy Groups & Disease Foundations in our Ecosystem, Diversity & Inclusion: Cultivating the Next Generation of Biotech Execs, and Fireside Chats on Pricing and on Maximizing Value in an M&A.

As part of their registration, Boston CEO&BD attendees will have full access to BioPharm America, which includes a variety of diverse content from AI Applications for Drug Delivery and Development, Drug Delivery Partnerships, a Startup Pitch Competition, and the ability to set up pre-scheduled one-to-one virtual partnering meetings with participants from all these areas with EBD Group’s gold-standard partneringONE® platform.

There are four full days of partnering on a 24-hour schedule to accommodate time zones, as well as live and recorded panel discussions, fireside chats, and company presentations.

Speakers at Boston CEO&BD include:

Bruce Booth, Partner, Atlas Venture
Andy Plump, President, Research & Development, Takeda
Barbara Fox, CEO, Rheos Medicines
Adelene Perkins, CEO, Infinity Pharmaceuticals
Patrick Tricoli, CEO USA & Global Head of Business Development, Nanobiotix
Noubar Afeyan, Founder & CEO, Flagship Pioneering

Save $200 with the early bird rate if you register before July 24. Reserve your spot now.

About LeadingBiotech 
LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit:https://leadingbiotech.com/.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Wendy Nelson
Visit website